Together, these results suggest that although GLUT1 overexpression is a key driver of glucose uptake, insulin signaling also contributes to the metabolic and oncogenic pathways underlying HNSCC progression. The gene discussed is SLC2A1; the disease is head and neck squamous cell carcinoma.